Headline
The latest stories from AHA Today.
The Food and Drug Administration recently authorized the temporary import of hydromorphone hydrochloride injection from Canada to address a critical shortage of the drug, an opioid pain medication.
Health care and public health professionals can register to attend a Sept. 19-20 workshop in Omaha, Neb., on preparing for emerging infectious diseases, such as Ebola.
In children, antibiotics are the leading cause of emergency department visits for adverse drug events.
The AHA today expressed support for and urged all senators to support an amendment to the Labor, Health and Human Services and Education appropriations bill that would help address the out-of-control cost of prescription drugs.
The Campaign for Sustainable Rx Pricing, of which the AHA is a founding member, today joined more than a dozen other health organizations in urging the Food and Drug Administration to finalize guidance critical to increasing competition in the biologics marketplace and expanding access to more…
The Department of Health and Human Services today issued a request for information seeking input on reporting criteria for the Electronic Health Record Reporting Program required by the 21st Century Cures Act.
Nearly half of Ohio’s Medicaid expansion new enrollees reported improvement in their overall health status since enrolling in Medicaid, compared to 3.5 percent who said their health had worsened, according to a report released by the state’s Department of Medicaid.
The AHA’s Hospitals Against Violence initiative and AHA’s Health Research & Educational Trust’s Hospital Improvement Innovation Network Aug. 27 at 12 p.m. ET will host a webinar on preventing violence in the workplace.
The Centers for Medicare & Medicaid Services today in a letter to state Medicaid directors outlined its current policies related to budget neutrality for Medicaid demonstration projects authorized under Section 1115 of the Social Security Act and provided states insights into the agency’s…
The departments of Health and Human Services and the Treasury today approved a Section 1332 waiver for Maryland to implement a five-year reinsurance program for its individual health insurance market beginning in 2019.